Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 117 for “"Phase I-II"”.

  1. Bayesian adaptive designs in phase I/II clinical trials

    … both toxicity and efficacy outcomes in a blended phase I/II fashion. A further challenge arises when all the true efficacy data cannot be obtained quickly after the treatment, so that surrogate markers are instead used (e.g, in cancer trials). In this thesis, we first propose a framework to …

    umn Repository record for Bayesian adaptive designs in phase I/II clinical trials (opens in a new tab)

  2. Implementierung eines kardialen Begleitmonitorings im Kontext experimenteller Tumortherapie (insbesondere Phase I/II Studien) zur frühen Detektion potenzieller Kardiotoxizität

    … eine Erweiterung des im Rahmen onkologischer Phase I/II Studien bereits implementierten kardiologischen Begleitmonitorings dar. Insgesamt 90 Studienpatienten der Early Clinical Trial Unit des Comprehensive Cancer Centers Mainfranken wurden möglichst über einen Zeitraum von sechs Monaten …

    wurz-thes Repository record for Implementierung eines kardialen Begleitmonitorings im Kontext experimenteller Tumortherapie (insbesondere Phase I/II Studien) zur frühen Detektion potenzieller Kardiotoxizität (opens in a new tab)

  3. Les cellules stromales mésenchymateuses participent au conditionnement ischémique rénal : contribution translationnelle d’une étude clinique de phase I/II en transplantation rénale et d’un modèle murin d’ischémie/reperfusion rénale

    … concerne une étude non randomisée contrôlée de phase I-II évaluant l'innocuité et la tolérance d'une seule perfusion de CSM derivées de moelle ossseuse d’un donneur tiers chez 10 patients greffés rénaux à partir d’un donneur décédé. Les CSM ont été administrées immédiatement après la TxR, en …

    liege Repository record for Les cellules stromales mésenchymateuses participent au conditionnement ischémique rénal : contribution translationnelle d’une étude clinique de phase I/II en transplantation rénale et d’un modèle murin d’ischémie/reperfusion rénale (opens in a new tab)

  4. Statistical Methods for Cancer Research

    Phase I/II clinical trial design is pivotal for achieving optimal therapeutic effect in immunotherapy and drug combination therapy for cancer treatment. Additionally, the identification of biomarkers associated with the risk of severe complications during cancer therapy is a crucial research area. …

    iupui Repository record for Statistical Methods for Cancer Research (opens in a new tab)

  5. Bayesian Adaptive Dose-Finding Clinical Trial Designs with Late-Onset Outcomes

    The late-onset outcome issue is common in early phase dose- nding clinical trials. This problem becomes more intractable in phase I/II clinical trials because both toxicity and e cacy responses are subject to the late-onset outcome issue. The existing methods applying for the phase I trials cannot …

    iupui Repository record for Bayesian Adaptive Dose-Finding Clinical Trial Designs with Late-Onset Outcomes (opens in a new tab)

  6. Biomechanical Comparison of a Rounded Outsole Shoe and Traditional Outsole Shoe

    … during level and uphill walking across phases of stance. Twelve participants, 7 males (75.1±9.3 kg, 173.6±3.6 cm, 22.9±3.5 yrs) and 5 females (56.5±5.1 kg, 158.3±4.5 cm, 25.4±11.1 yrs) granted written consent and preferred walking speed was determined. An accelerometer (480 Hz) was …

    unlv Repository record for Biomechanical Comparison of a Rounded Outsole Shoe and Traditional Outsole Shoe (opens in a new tab) Download PDF for Biomechanical Comparison of a Rounded Outsole Shoe and Traditional Outsole Shoe (opens in a new tab)

  7. Novel Bayesian Adaptive Designs for Early Phase Oncology Clinical Trials

    … novel Bayesian adaptive designs for early phase oncology trials. First, we discuss a Phase I-II trial design for therapeutic cancer vaccines and propose a two-stage approach for identifying the optimal vaccination schedule from multiple candidate vaccination schedules. We model binary …

    umn Repository record for Novel Bayesian Adaptive Designs for Early Phase Oncology Clinical Trials (opens in a new tab)

  8. Untersuchung zur Sicherheit, Verträglichkeit und maximal verträglichen Dosis eines mikroverkapselten Lieschgraspollenextraktes zur oralen Immuntherapie bei Probanden mit Gräserpollenallergie

    … doppeltblinden, placebokontrollierten Studie der Phase I/II wurde die Sicherheit und Verträglichkeit einer neuen Formulierung von mikroverkapselten Lieschgraspollenextrakt untersucht. Das Prüfpräparat wurde oral an Patienten die an einer allergische Rhinitis aufgrund einer Graspollenallergie …

    fu-berlin Repository record for Untersuchung zur Sicherheit, Verträglichkeit und maximal verträglichen Dosis eines mikroverkapselten Lieschgraspollenextraktes zur oralen Immuntherapie bei Probanden mit Gräserpollenallergie (opens in a new tab)

  9. Perceptions of principals and teachers regarding the West Virginia mandated performance evaluation of teachers.

    … asked why teachers do not choose to enter the Phase I/II professional growth and development cycle. Surveys were mailed to 218 principals and 270 teachers, randomly selected from the population of public school principals and teachers by staff from the West Virginia Department of Education. A …

    wvu Repository record for Perceptions of principals and teachers regarding the West Virginia mandated performance evaluation of teachers. (opens in a new tab)

  10. Transparent and Efficient Designs for Clinical Trials

    Modern early phase clinical trials are integral in assessing the efficacy and safety of new treatments. Traditional methodologies heavily rely on complex parametric models to determine dose-response relationships. They come with inherent challenges: difficulty in practical validation, potential for …

    iupui Repository record for Transparent and Efficient Designs for Clinical Trials (opens in a new tab)

  11. Modifikation der Antigenpräsentation zur Induktion von Tumorimmunität

    … konnten T-Zellen gegen Leukämie-assoziierte Antigene im peripheren Blut nachgewiesen werden. Zum Teil hatten diese T-Zellen jedoch ein aberrantes Zytokin-Sekretionsprofil. In einer Phase-I/II-Vakzinierungs-Studie wurden unbestrahlte bcr/abl+ autologe DC als subkutane Vakzine bei …

    fu-berlin Repository record for Modifikation der Antigenpräsentation zur Induktion von Tumorimmunität (opens in a new tab)

  12. Hepatic Phase I and II Biotransformation Kinetics in Fishes: A Comparative Study

    … the similarities and dissimilarities on their phase I and II biotransformation capabilities using microsomal and cytosolic fractions of the liver. This research had three main objectives: 1) a comparison among the kinetics of the 8 species using model substrates, 2) farm-raised and …

    maryland Repository record for Hepatic Phase I and II Biotransformation Kinetics in Fishes: A Comparative Study (opens in a new tab)

  13. Neue Therapieansätze für die Behandlung Embryonaler Tumoren im Kindesalter

    … USA und in China schon in zahlreichen klinischen Phase-I/II-Studien getestet wird, gibt es in Deutschland noch keine Einrichtung mit einem fest etablierten Prozess der GMP-gerechten CAR-T-Zellherstellung. Wir stehen kurz vor der Beantragung einer Herstellungserlaubnis beim Landesamt für Gesundheit …

    fu-berlin Repository record for Neue Therapieansätze für die Behandlung Embryonaler Tumoren im Kindesalter (opens in a new tab)

  14. Chemical mechanisms underlying the medicinal activity of metabolically-activated N-oxide antitumor agents

    … undergoing in various clinical trials including Phase I, II and III. Anti-cancer activity of TPZ derives from its ability to cause the DNA strand cleavage in oxygen poor environment found in solid tumors. However, the exact nature of DNA damaging agent produced from activated TPZ is not well …

    missouri Repository record for Chemical mechanisms underlying the medicinal activity of metabolically-activated N-oxide antitumor agents (opens in a new tab)

  15. Bayesian Models for Clinical Trials and Survival Analysis

    … death after effusion. In the second project, a phase I clinical trial is discussed that allows dose-finding for multiple heterogeneous patient subgroups simultaneously. This extends the time-to-event Continual Reassessment Method (TITE-CRM) by borrowing strength among patient subgroups. If the …

    rice Repository record for Bayesian Models for Clinical Trials and Survival Analysis (opens in a new tab)

  16. Preclinical development of T cell products for immunotherapy after allogeneic hematopoietic stem cell transplantation

    … with two such products having proceeded to phase I/II trials with promising results despite complex production protocols. Our approach aims to replicate the feto-maternal tolerance mechanism mediated by the immunosuppressive Human Leukocyte Antigen-G (HLA-G) molecule, which is naturally …

    greece Repository record for Preclinical development of T cell products for immunotherapy after allogeneic hematopoietic stem cell transplantation (opens in a new tab)

Page 1 of 6